SEC Form 4 · accession 0001185185-26-002968
QTREX Quantum Ltd. · QTEX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hayon Daniella Yechezkely
Officer — Chief Technology Officer
Period of report
Jul 6, 2026
Accepted (ET)
Jul 14, 2026 · 5:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001837493
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 6, 2026 | A | 550,000 | $0.00 | A | 1,330,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event.